Lymphogranuloma venereum: an emerging problem in Poland.
Chlamydia trachomatis
lymphogranuloma venereum
men who have sex with men
sexually transmitted disease
Journal
Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
09
10
2020
accepted:
25
04
2020
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
12
8
2022
Statut:
ppublish
Résumé
Lymphogranuloma venereum (LGV) is a sexually transmitted disease that increases in incidence, particularly in more developed countries worldwide. LGV is caused by Chlamydia trachomatis serovars/genovars L1-3, including their subvariants, and in Europe mostly affects men who have sex with men (MSM). It can be asymptomatic but has now emerged as a frequent cause of severe proctitis/proctocolitis, especially in MSM. LGV has often been misdiagnosed as C. trachomatis serovars/genovars D-K infection. It is essential with accurate diagnosis that ensures appropriate treatment and protects the patient from complications and sequelae as well as from the consequences of misdiagnosis, e.g. as inflammatory bowel disease or cancer. We present a systematic review of LGV and two new LGV cases diagnosed in Poland.
Identifiants
pubmed: 35950128
doi: 10.5114/ada.2020.101466
pii: 42602
pmc: PMC9326913
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
587-593Informations de copyright
Copyright: © 2020 Termedia Sp. z o. o.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
JRSM Open. 2016 Dec 01;8(1):2054270416660933
pubmed: 28203380
Bull World Health Organ. 2019 Aug 01;97(8):548-562P
pubmed: 31384073
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1821-1828
pubmed: 31243838
Przegl Epidemiol. 2018;72(1):45-51
pubmed: 29667379
BMC Infect Dis. 2014 Aug 26;14:464
pubmed: 25158743
Infect Immun. 2001 Feb;69(2):968-76
pubmed: 11159992
Microb Genom. 2019 Nov;5(11):
pubmed: 31697227
Infect Drug Resist. 2015 Mar 27;8:39-47
pubmed: 25870512
Mini Rev Med Chem. 2017;17(4):328-337
pubmed: 27515715
Emerg Infect Dis. 2016 Nov;22(11):1945-1947
pubmed: 27767927
Eur J Gastroenterol Hepatol. 2020 Mar;32(3):454-457
pubmed: 31851086
J Bacteriol. 2012 Dec;194(23):6574-85
pubmed: 23042990
Sex Transm Dis. 2019 Oct;46(10):689-692
pubmed: 31259852
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S865-73
pubmed: 26602624
Sex Transm Infect. 2014 Jun;90(4):262-8
pubmed: 24493859
Clin Infect Dis. 2004 Oct 1;39(7):996-1003
pubmed: 15472852
BMC Res Notes. 2014 Jun 10;7:355
pubmed: 24915990
J Antimicrob Chemother. 2015 Apr;70(4):961-4
pubmed: 25480490
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Sex Transm Infect. 2019 May;95(3):169-170
pubmed: 30554142
Clin Microbiol Infect. 2011 Dec;17(12):E21-3
pubmed: 21951622
Sex Transm Infect. 2014 Jun;90(4):275-8
pubmed: 24431182
APMIS. 2016 Dec;124(12):1078-1086
pubmed: 27859689
Sex Transm Dis. 2008 Feb;35(2):203-8
pubmed: 18091565
BMC Infect Dis. 2011 Mar 18;11:70
pubmed: 21418569
Emerg Infect Dis. 2016 Oct;22(10):1778-84
pubmed: 27513890
Sex Transm Infect. 2010 Aug;86(4):278-9
pubmed: 20660591
Sex Transm Infect. 2020 Mar;96(2):137-142
pubmed: 31235527
Curr Rheumatol Rep. 2019 Nov 19;21(11):63
pubmed: 31741118
Curr Opin Infect Dis. 2019 Feb;32(1):43-50
pubmed: 30507675
Front Microbiol. 2017 Nov 13;8:2195
pubmed: 29180986
Mini Rev Med Chem. 2015;15(2):93-103
pubmed: 25751258
Sex Transm Dis. 2020 Mar;47(3):162-164
pubmed: 31876865